Page 15 - Polypeptide Group News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Generic Segment to Grow at Faster Pace during Forecast Period Peptide Therapeutics Market is expected to reach US$ 50,003.15 million by 2027 from US$ 24,878.55 million in 2019; it is estimated to grow at a CAGR of 9.2% from 2020 to 2027. The report highlights trends prevailing in the market, and the factors driving and hindering the market growth. The growth of the peptide therapeutics market is mainly attributed to the growing investments on peptide therapeutics and increasing prevalence of metabolic disorders and infectious diseases. However, operational limitations of peptides deter the ma...

PolyPeptide Group plans IPO and listing on the Swiss Stock Exchange EQS Group-News: PolyPeptide Group / Key word(s): IPO 12.04.2021 / 07:00 NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES OF AMERICA, CANADA, JAPAN OR AUSTRALIA OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. FOR RELEASE IN SWITZERLAND - THIS IS A RESTRICTED COMMUNICATION AND YOU MUST NOT FORWARD IT OR ITS CONTENTS TO ANY PERSON TO WHOM FORWARDING THIS COMMUNICATION IS PROHIBITED BY THE LEGENDS CONTAINED HEREIN. PolyPeptide Grou...

3 Min Read ZURICH (Reuters) - PolyPeptide Group, controlled by a foundation of Swedish billionaire adventurer Frederik Paulsen Jr., said Monday it plans to list a 40% stake on the Swiss stock exchange to finance the contract drug maker’s growth. The company, which makes ingredients for U.S.-based Novavax Inc’s, COVID-19 vaccine candidate, plans to list in the second quarter. It plans to place existing shares and a primary offering, with some proceeds to go for potential acquisitions. PolyPeptide is eyeing “adjacent” business areas, in not only oligonucleotides that can be used in gene...

Share this article Share this article ResearchAndMarkets.com's offering. This report provides insights into the potential application of peptide therapeutics and their mode of action in the management of different cancers. In addition to this, the report also provide data on the pricing, sales and dosage of the currently available peptide based therapeutics and the robust clinical pipeline which are expected to enter the market in next coming years. Moreover, the various key players which are indulging in research activities for the development of novel peptides is also added in the report. G...

Mar 3, 2021 9:45am COVID-19 vaccine shipments are now underway. Here are the supply chains tasked with producing billions of doses. (nevodka/iStock/Getty Images Plus/Getty Images) As COVID-19 gained steam worldwide last spring, little was known about the disease and the havoc it would wreak on the world. A year later, vaccines offer hope in the fight against the virus, but it will be a monumental task to produce them and deliver them around the planet. That these vaccines were invented, put through clinical testing and either have been rolled out or are nearing distribution is an accomplishm...